Research and Markets has announced the addition of the "Epigenetic Therapy in Oncology: Analytical Tool" report to their offering.
Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals from a business development, drug development or investment perspective.
The Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering:
- Target Scouting
- Early & Late Stage Pipeline Analysis
- Biomarker/Companion Diagnostic Analysis
- Deal & Alliance Analysis
- Combination Therapy Analysis
- Indication Selection & Expansion Analysis
- First-in-Class Analysis
- Drug Repositioning
- Pipeline Analysis by Targeted Pathways
For more information about this report visit http://www.researchandmarkets.com/research/r9knw7/epigenetic.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161012005829/en/Business Wire
Last updated on: 12/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.